Use of the Revised Cardiac Risk Index (RCRI) for Perioperative Cardiac Risk Assessment

Preference for RCRI over the Gupta (NSQIP‑MICA) Calculator

• The Canadian Cardiovascular Society recommends the RCRI as the primary peri‑operative cardiac risk tool because the Gupta calculator was derived without systematic peri‑operative troponin monitoring and consequently missed > 50 % of myocardial infarctions. [1][3]
• Derivation studies of the NSQIP‑MICA and ACS‑NSQIP indices showed apparently better discrimination than the RCRI, but this advantage is misleading since patients were not routinely screened with troponin, leading to under‑estimation of true cardiac risk. [1][3]
• No external validation of the Gupta calculator has been performed in a cohort with systematic troponin surveillance after non‑cardiac surgery, representing a critical methodological limitation. [1][2]

Validation and Performance of the RCRI

• The RCRI has been validated in 792,740 patients across 24 independent studies, making it the most extensively validated clinical index for peri‑operative cardiac complications. 4
• External validation studies that incorporated systematic troponin monitoring produced higher 30‑day cardiac event rates than the original derivation cohort, reflecting more sensitive detection of myocardial injury. [1][4]
• In a 2019 external validation of 870 vascular‑surgery patients with troponin monitoring, the RCRI demonstrated moderate discrimination (c‑statistic = 0.60; 95 % CI 0.54‑0.65), indicating limited predictive performance in this high‑risk group. 4

Patient Population and Risk Factors for Applying the RCRI

• Eligibility: Adults ≥ 45 years (or 18‑44 years with known significant cardiovascular disease) scheduled for elective non‑cardiac surgery should be assessed with the RCRI. 5
• Six RCRI risk factors (1 point each):
  These definitions are supported by the Canadian cardiology literature. 4

Updated RCRI‑Based 30‑Day Cardiac Event Estimates

These updated rates are higher than the original RCRI estimates because they derive from external validation cohorts that used troponin (more sensitive than CK‑MB) and included emergency surgeries. [1][4]

Guideline Recommendations (Societal Guidance)

• The 2024 American Heart Association / American College of Cardiology (AHA/ACC) guidelines give a Class 2a recommendation to employ validated cardiovascular risk‑prediction tools—preferably the RCRI or the ACS‑NSQIP calculator—for adults with known cardiovascular disease undergoing non‑emergent, non‑cardiac surgery. 6

Complementary Assessments to Enhance Risk Stratification

• For patients > 70 years, mandatory frailty screening using the Modified Frailty Index (MFI‑5) or Rockwood Frailty Deficit Index adds prognostic information beyond the RCRI. 6
• In intermediate‑ and high‑risk patients, functional‑status testing (e.g., two‑flight‑of‑stairs test or Duke Activity Status Index) helps decide whether further cardiac testing is warranted. 6
• Measuring cardiac troponin pre‑operatively and at 24 h and 48 h post‑operatively improves detection of peri‑operative myocardial injury. 6